V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250008153 | 250005600 | null | null | Disease modification (D) | 2016-04-19 | 2016-04-19 | Pemetrexed | Y | N | 250017324 | CARBO + GEFITINIB + PEMETREXED |
| 250008154 | 250005601 | 1.67 | 98 | Palliative (P) | 2018-03-02 | 2018-03-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250017325 | TRIAL |
| 250008155 | 250005601 | 1.6 | 51.8 | Palliative (P) | 2017-11-07 | 2017-11-08 | Cisplatin 100 + RT(H&N) 1 day | N | N | 250017325 | CHOP R + BORTEZOMIB |
| 250008156 | 250005602 | null | 76.9 | Curative (C) | 2018-01-16 | 2018-01-09 | CARBOPLATIN | 02 | N | 250017372 | PEMBROLIZUMAB |
| 250008158 | 250005604 | 1.65 | null | Curative (C) | 2017-04-16 | 2017-04-21 | Pemetrexed | Y | N | 250017447 | VINORELBINE |
| 250008159 | 250005605 | 1.77 | 83 | Disease modification (D) | 2016-03-27 | 2016-03-27 | Azacitidine | 02 | N | 250017501 | TRIAL |
| 250008160 | 250005606 | null | null | Palliative (P) | 2017-10-22 | 2017-10-23 | Azacitidine | 02 | N | 250017514 | GEMCITABINE |
| 250008161 | 250005607 | null | 59.45 | Disease modification (D) | 2016-01-22 | 2016-01-22 | TEMOZOLOMIDE | null | N | 250017557 | AZACITIDINE |
| 250008162 | 250005607 | 1.57 | 97.2 | Disease modification (D) | 2016-11-27 | 2016-11-27 | Carboplatin + Docetaxel | N | N | 250017557 | IPM |
| 250008163 | 250005608 | 1.75 | 56.4 | Palliative (P) | 2015-02-24 | 2015-02-24 | EOX | N | N | 250017705 | FIGARO TRIAL |
| 250008164 | 250009933 | null | 69.2 | Curative (C) | 2018-09-24 | 2018-10-20 | Vinorelbine (oral) | 2 | N | 250017793 | TRIAL |
| 250008165 | 250005609 | null | null | Curative (C) | 2015-12-08 | 2015-12-09 | ABVD | 2 | N | 250017799 | TRIAL |
| 250008166 | 250005610 | 0 | 76.9 | Disease modification (D) | 2016-07-01 | 2016-07-07 | Carboplatin AUC 2 - 5 | N | N | 250017928 | TRIAL |
| 250008167 | 250005611 | 1.77 | 71 | Disease modification (D) | 2016-01-28 | 2016-02-10 | HSV1716 | 02 | N | 250018033 | BENDAMUSTINE |
| 250008168 | 250009934 | 1.64 | 95.5 | Palliative (P) | 2018-03-12 | 2018-03-20 | IPM | N | N | 250018091 | PEMETREXED |
| 250008169 | 250009934 | 1.79 | 103 | Palliative (P) | 2017-04-06 | 2017-04-07 | Abiraterone | 2 | N | 250018091 | CISPLATIN + PACLITAXEL |
| 250008170 | 250009934 | 1.71 | 57.35 | Adjuvant (A) | 2016-09-30 | 2016-10-14 | FLUOROURACIL + MITOMYCIN | 1 | null | 250018091 | TRIAL |
| 250008171 | 250005612 | null | null | Curative (C) | 2015-11-01 | 2015-11-07 | Trial Unspecified | N | N | 250018328 | PEMETREXED |
| 250008172 | 250009935 | null | 72 | Disease modification (D) | 2015-12-24 | 2015-12-24 | Trial Unspecified | N | N | 250018338 | TRIAL |
| 250008173 | 250009935 | 1.72 | 72 | Disease modification (D) | 2014-05-17 | 2014-05-17 | Cytarabine Low Dose | N | N | 250018338 | GEMCITABINE |
| 250008174 | 250009935 | 1.64 | 87.8 | Palliative (P) | 2014-12-08 | 2014-12-08 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 250018338 | PEMETREXED |
| 250008175 | 250009935 | 1.81 | 74.5 | Disease modification (D) | null | 2018-02-09 | MESO-02 TRIAL | Y | N | 250018338 | TRIAL |
| 250008176 | 250009935 | 1.6 | 81.2 | Palliative (P) | 2017-06-22 | 2017-06-26 | CARBOPLATIN | 2 | N | 250018338 | VINORELBINE |
| 250008177 | 250005613 | 1.75 | 61.2 | Not known (9) | 2015-01-20 | 2015-01-20 | CHOP R | 2 | N | 250018524 | CISPLATIN |
| 250008178 | 250005614 | 1.67 | 84 | Palliative (P) | 2015-09-29 | 2015-09-28 | Cisplatin + Paclitaxel | 2 | N | 250018640 | TRIAL |
| 250008179 | 250005614 | 0 | 65.2 | Disease modification (D) | 2015-12-26 | 2015-12-26 | Pemetrexed | 02 | N | 250018640 | BORTEZOMIB |
| 250008180 | 250005615 | null | 88.7 | Curative (C) | 2017-11-02 | 2017-11-02 | Azacitidine | 2 | N | 250018711 | CHLORAMBUCIL |
| 250008181 | 250005615 | 0 | 67 | Adjuvant (A) | 2015-09-02 | 2015-09-24 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250018711 | DOCETAXEL |
| 250008182 | 250005616 | 1.83 | 76.6 | Palliative (P) | 2018-08-17 | 2018-08-23 | AML18 PILOT TRIAL | 2 | Y | 250018735 | CISPLATIN + PACLITAXEL |
| 250008183 | 250005616 | 0 | null | Curative (C) | 2014-03-29 | 2014-04-09 | TEMOZOLOMIDE | N | N | 250018735 | TRIAL |
| 250008184 | 250005616 | 1.7 | 69 | Palliative (P) | 2016-12-03 | 2017-01-07 | Carboplatin + Etoposide iv&po | null | null | 250018735 | CAPECITABINE + OXALIPLATIN |
| 250008185 | 250005617 | 0 | 79.8 | Palliative (P) | 2018-11-17 | 2018-11-20 | Enzalutamide | 1 | N | 250019028 | CYTARABINE |
| 250008186 | 250005617 | 1.72 | 98 | Palliative (P) | 2014-07-11 | 2014-07-11 | Carboplatin + Paclitaxel (weekly) | 2 | N | 250019028 | TRIAL |
| 250008187 | 250005617 | 1.75 | 111.2 | Palliative (P) | 2018-09-07 | 2018-09-07 | Carboplatin AUC 6 - 10 | Y | N | 250019028 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250008188 | 250005618 | 1.63 | null | Palliative (P) | 2017-10-21 | 2017-10-26 | Carboplatin + Etoposide iv&po | N | N | 250019175 | AML18 TRIAL |
| 250008189 | 250005619 | null | null | Disease modification (D) | 2017-04-06 | 2017-04-06 | GemCarbo Days 1+8 | Y | N | 250019230 | PEMETREXED |
| 250008190 | 250005620 | 1.67 | 86.4 | Curative (C) | 2017-01-20 | 2017-02-10 | DOXORUBICIN | 1 | N | 250019336 | PEMETREXED |
| 250008191 | 250005621 | 1.66 | 62.4 | Curative (C) | null | 2017-11-14 | RUXOLITINIB | null | N | 250019482 | IPM |
| 250008192 | 250005621 | 0 | 97.2 | Palliative (P) | 2017-08-13 | 2017-08-22 | Carboplatin + Vinorelbine IV | 02 | N | 250019482 | VINORELBINE |
| 250008193 | 250005622 | 1.55 | 91.6 | Palliative (P) | 2017-09-22 | 2017-09-22 | MESO-02 TRIAL | N | N | 250019583 | BCG |
| 250008194 | 250005623 | 1.67 | 88 | Palliative (P) | 2018-09-15 | 2018-09-15 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 250019592 | RUXOLITINIB |
| 250008195 | 250005623 | -1 | 81 | Adjuvant (A) | 2018-04-24 | 2018-05-08 | CARBOPLATIN + ETOPOSIDE | 02 | N | 250019592 | CISPLATIN + PACLITAXEL |
| 250008196 | 250005624 | 1.55 | 0 | Disease modification (D) | 2016-10-17 | 2016-10-18 | IPM | N | N | 250019777 | TRIAL |
| 250008197 | 250009942 | 1.57 | null | Palliative (P) | 2018-11-29 | 2018-12-05 | IPM | null | null | 250019822 | CARBOPLATIN + PACLITAXEL |
| 250008198 | 250005625 | 1.37 | 77.7 | Disease modification (D) | 2013-08-04 | 2013-08-29 | Carboplatin + Etoposide IV 3 day | 02 | Y | 250019890 | TRIAL |
| 250008199 | 250005626 | 1.74 | 65.5 | Palliative (P) | null | 2016-01-09 | Temozolomide 150mg/m2 | null | null | 250020022 | TRIAL |
| 250008200 | 250005627 | null | null | null | 2014-09-03 | 2014-10-02 | Bortezomib +/- Dexamethasone | N | N | 250020140 | CYTARABINE |
| 250008201 | 250009943 | 1.4 | 74.5 | Disease modification (D) | 2018-09-17 | 2018-09-25 | Vinorelbine (oral) | N | N | 250020143 | TRIAL |
| 250008202 | 250009943 | 1.73 | 44 | Palliative (P) | 2018-07-24 | 2018-07-27 | GEMCARBO | null | N | 250020143 | VINORELBINE |
| 250008203 | 250012424 | 1.8 | 0 | Palliative (P) | 2016-07-12 | 2016-07-13 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | N | N | 250020213 | CISPLATIN |